CytomX Therapeutics Inc (CTMX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

151 OYSTER POINT BLVD. SOUTH SAN FRANCISCO, CA 94080

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company. The Company focuses on developing probody therapeutics for the treatment of cancer. CytomX Therapeutics serves pharmaceutical industries throughout the United States.

Data as of 2021-05-08 11:42:10 -0400
Market Cap555.845 Million Shares Outstanding65.011 Million Avg 30-day Volume1.279 Million
P/E Ratio-16.9027 Dividend Yield EPS-0.713
Price/Sales5.54 Debt to Equity7.2 EBITDA-46.178 Million
Price to Book Value11.16 Forward PE-5.55 Enterprise Value239.726 Million
Total Cash316.119 Million Current Debt100.924 Million Gross Profit100.362 Million
BETA0.97415 52-week High/Low15.44 / 6.25 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from CTMX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 128 130 -1.54% 46 (2.76%) 49 (3.05%) -6.12%
13F shares: 37.996 Million 36.574 Million 3.89% 20.057 Million 18.352 Million 9.29%
% Ownership 82.1985 79.1237 3.89% 43.3902 39.701 9.29%
New Positions: 11 16 -31.25% 3 5 -40.0%
Increased Positions 43 44 -2.27% 17 18 -5.56%
Closed Positions 14 20 -30.0% 6 12 -50.0%
Reduced Positions 51 47 8.51% 18 20 -10.0%
Total Calls 23.5 Thousand 10.6 Thousand 121.7%
Total Puts 0 1.2 Thousand -100.0%
PUT/CALL Ratio 0.0 0.11 -100.0% -100.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CTMX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CTMX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

100 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

100 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MCCARTHY SEAN A. PRESIDENT AND CEO

  • Officer
  • Director
299,037 2021-03-31 7

ROWLAND LLOYD A GENERAL COUNSEL

  • Officer
125,000 2021-02-26 1

PETERSON AMY C. EVP, CHIEF DEVELOPMENT OFFICER

  • Officer
250,000 2021-02-26 2

HANNAH ALISON L. CHIEF MEDICAL OFFICER

  • Officer
175,000 2021-02-26 1

CAMPOY CARLOS CHIEF FINANCIAL OFFICER

  • Officer
100,000 2021-02-26 2

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BVF I GP LLC

BIOTECHNOLOGY VALUE FUND II LP

BVF II GP LLC

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF GP HOLDINGS LLC

BVF INC/IL

LAMPERT MARK N

  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
5,468,599 2021-01-25 2

MOHINDRU MANI

  • Director
0 2020-12-16 2

GLUCK FREDERICK W

  • Director
0 2020-06-17 1

JONES ELAINE V

  • Director
0 2020-06-17 1

YOUNG MATTHEW P.

  • Director
0 2020-06-17 1

SCARLETT JOHN A

  • Director
0 2020-06-17 1

FUCHS CHARLES S.

  • Director
0 2020-06-17 1

MEYERS JAMES R

  • Director
0 2020-06-17 1

GILBERT HALLEY E

  • Director
0 2020-06-17 1

KAVANAUGH WILLIAM MICHAEL CSO, HEAD RES.&NON-CLIN. DEV.

  • Officer
0 2020-02-14 0

KNIFSEND ROBIN PRINCIPAL ACCOUNTING OFFICER

  • Officer
0 2020-02-14 0

HUMPHREY RACHEL CHIEF MEDICAL OFFICER

  • Officer
0 2019-01-25 0

RAY DEBANJAN CHIEF FINANCIAL OFFICER

  • Officer
0 2019-01-25 0

HUH HOYOUNG

  • Director
0 2018-06-13 0

THIRD ROCK VENTURES LP

THIRD ROCK VENTURES GP, L.P.

TRV GP, LLC

LEVIN MARK J

STARR KEVIN P

TEPPER ROBERT I

  • 10% Owner
No longer subject to file 2017-10-18 0

TEPPER ROBERT I

  • 10% Owner
4,349,864 2017-10-04 0

EXTER NEIL

  • Director
0 2017-06-20 0

MCCOURT MARION

  • Director
0 2017-06-20 0

GOELTZ II ROBERT C. CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2017-05-12 0

STARR KEVIN P

  • 10% Owner
5,201,767 2017-04-12 0

CANAAN IX L.P.

CANAAN PARTNERS IX LLC

  • Director
2,494,381 2017-03-27 0

LADD CYNTHIA J SENIOR VP AND GENERAL COUNSEL

  • Officer
0 2017-01-25 0

SHANNON TIMOTHY M

  • Director
3,244,829 2016-11-29 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2015-10-14 0

HADLEY HARBOR MASTER INVESTORS (CAYMAN) L.P.

  • 10% Owner
No longer subject to file 2015-10-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MCCARTHY SEAN A. - Director - Officer PRESIDENT AND CEO

2021-04-02 17:37:50 -0400 2021-03-31 M 100,000 $1.13 a 306,894 direct -2.2673 -19.5704 0.0 1 -19.5704 6

MCCARTHY SEAN A. - Director - Officer PRESIDENT AND CEO

2021-04-02 17:37:50 -0400 2021-03-31 M 100,000 d 92,143 direct

MCCARTHY SEAN A. - Director - Officer PRESIDENT AND CEO

2021-04-02 17:37:50 -0400 2021-03-31 S 100,000 $7.49 d 206,894 direct yes -2.2673 -19.5704 0.0 1 -19.5704 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 22:15:04 UTC -0.4458 0.4958 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 21:45:02 UTC -0.4458 0.4958 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 21:15:02 UTC -0.4458 0.4958 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 20:45:03 UTC -0.4458 0.4958 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 20:15:03 UTC -0.4458 0.4958 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 19:45:03 UTC -0.4458 0.4958 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 19:15:03 UTC -0.4458 0.4958 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 18:45:03 UTC -0.4458 0.4958 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 18:15:03 UTC -0.4458 0.4958 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 17:45:02 UTC -0.4458 0.4958 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 17:15:03 UTC -0.4458 0.4958 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 16:45:03 UTC -0.4458 0.4958 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 16:15:03 UTC -0.4458 0.4958 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 15:45:03 UTC -0.4458 0.4958 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 15:15:03 UTC -0.4458 0.4958 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 14:45:04 UTC -0.3331 0.3831 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 14:15:04 UTC -0.3331 0.3831 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 13:45:04 UTC -0.3331 0.3831 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 13:15:03 UTC -0.3331 0.3831 1300000
CYTOMX THERAPEUTICS INC CTMX 2021-05-10 12:45:02 UTC -0.3331 0.3831 1200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund CTMX -1.0 shares, $-7.67 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund CTMX -3.0 shares, $-23.01 2020-03-31 N-PORT

Elevate your investments